Just some thoughts from a overthinking relatively new BOT investor. . .
After digesting the webinar and reading between the lines I am now convinced the IT platforms that will underpin the sofdra release will be company making in their own right. . .
It is quite possible that the "instructions for use" were actually available but were intended to be included digitally within the SOFRA app/platform to draw patients/practitioners into the IT ecosystem. BUT . . . the FDA needed the paper written ones included.
This would explain why the resubmission was so timely.
I have said it before but I think BOT is waiting for FDA approval not only for drug commercialisation but also for showcasing the revolutionary IT platforms. . . script refill, practitioner/patient care (aka aftercare)
Then other companies can pay us $$$ for product release and the aftercare . . .
AIMO
Just some thoughts from a overthinking relatively new BOT...
-
- There are more pages in this discussion • 553 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |